Other functions - cancer prevention agent development program: early phase clinical research
Ended Awarded Last action
- Contract number
- 75N91019F00129
- Awardee
-
The Univeristy Of Texas M.d. Anderson Cancer Center UEI S3GMKS8ELA16 Part of University Of Texas System
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,048,502
Award facts
- Contract value 99% obligated
-
- $2,048,502.23 Current, with exercised options
- $2,067,521.23 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 5 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Houston, TX 77030, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$7,043 | |
| Exercise an Option | $183,238 | |
| Exercise an Option | $260,813 | |
| Exercise an Option | $321,687 | |
| Exercise an Option | $565,667 | |
| Original award | $724,140 |
About this award
The National Cancer Institute (NCI) awarded a $2,067,521.23 delivery order contract to the University of Texas MD Anderson Cancer Center (MD Anderson) to conduct early phase clinical research for the Cancer Prevention Agent Development Program. This contract is a child under the larger Cancer Prevention Agent Development Program 2012-2017 indefinite delivery vehicle. MD Anderson, as a comprehensive cancer research and treatment center, will provide various services in support of this cancer prevention initiative, including preclinical studies, clinical trials, and correlative analyses. The University of Texas System is the parent organization for MD Anderson. This contract does not have a set-aside designation.
Quick answers
Who was awarded contract 75N91019F00129?
75N91019F00129 was awarded to The Univeristy Of Texas M.d. Anderson Cancer Center by National Cancer Institute (National Institutes of Health) on September 10, 2019.
How much is contract 75N91019F00129 worth?
The government has obligated $2,048,502 on 75N91019F00129. Its potential value, with all options, is $2,067,521.
Is contract 75N91019F00129 an order under another contract?
Yes. 75N91019F00129 is a delivery order under HHSN261201200034I, an indefinite delivery contract, on Cancer Prevention Agent Development Program 2012-2017.
Was contract 75N91019F00129 competed?
The extent of competition for 75N91019F00129 was full and open competition. The government received 5 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award